TransGenic Group Inc (2342)

Currency in JPY
207.0
0.0(0.00%)
Closed·
Advertisement
2342 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
204.0209.0
52 wk Range
182.0487.0
Key Statistics
Bid/Ask
206.00 / 207.00
Prev. Close
207
Open
205
Day's Range
204-209
52 wk Range
182-487
Volume
63.6K
Average Volume (3m)
73.72K
1-Year Change
2.4752%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2342 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Earnings

Latest Release
12/08/2026
EPS / Forecast
8.17 / --
Revenue / Forecast
3.66B / --
EPS Revisions
Last 90 days

Compare 2342 to Peers and Sector

Metrics to compare
2342
Peers
Sector
Relationship
P/E Ratio
104.5x−3.4x−0.3x
PEG Ratio
1.01−0.030.00
Price/Book
0.7x4.1x2.6x
Price / LTM Sales
0.3x15.0x2.9x
Upside (Analyst Target)
-63.6%64.3%
Fair Value Upside
Unlock17.5%9.2%Unlock

Transgenic Group Inc. develops, distributes, and licenses genetically modified animals and antibodies in Japan. It operates through Drug Discovery Support Business and Investment and Consulting Business segments. The company provides analysis of the function of individual genes in individuals, elucidation of the relationship between genes and pathology, production of disease model mice, gene expression analysis, and antibody production; clinical trials for pharmaceutical agents, such as bioequivalence studies; administrative services for clinical trials; clinical trials for foods for specified health uses; and hospital support. It also conducts non-clinical studies for pharmaceuticals, medical devices, chemical substances, and food development using small and large animals. In addition, the company offers services related to mergers and acquisitions, business revitalization, business succession, and investment business. The company was formerly known as Trans Genic Inc. and changed its name to Transgenic Group Inc. in October 2024. Transgenic Group Inc. was incorporated in 1998 and is headquartered in Fukuoka City, Japan.

Employees
227
Market
Japan

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
1.09M6.56%232.51M
Public Companies & Retail Investors
15.56M93.44%3.31B
Total
16.65M100.00%3.55B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
SBI Holdings, Inc.2.48%413,61888,101
Rakuten Investment Management, Inc.2.43%404,00086,052

People Also Watch

1,742.00
2962
-2.13%
27.0
4597
+3.85%
363.0
7777
+0.28%
958.0
6072
-4.20%
2,101.0
6330
-2.51%

FAQ

What Is the TransGenic Group (Tokyo: 2342) Share Price Today?

The TransGenic Group stock price today is 207.0 JPY.

What Stock Exchange Does TransGenic Group (2342) Trade On?

TransGenic Group is listed and trades on the Tokyo Stock Exchange.

What Is the Ticker (Stock Symbol) for TransGenic Group?

The stock symbol (also called a 'ticker') for TransGenic Group is "2342."

What Is the Current TransGenic Group Market Capitalisation?

As of today, TransGenic Group (Tokyo: 2342) market cap is 3.45B JPY.

What Is TransGenic Group's (2342) Earnings Per Share (TTM)?

The TransGenic Group EPS is currently 1.98 (Trailing Twelve Months).

When Is the Next TransGenic Group Earnings Date?

TransGenic Group's next earnings report will be released on 12/11/2026.

Is 2342 a Buy or Sell From a Technical Analyst Perspective?

Based on today's TransGenic Group moving averages and other technical indicators, the daily buy/sell signal for 2342 stock is Strong Sell.

How Many Times Has TransGenic Group Stock Split?

TransGenic Group has split 2 times. (See the 2342 stock split history page for full effective split date and price information.)

How Many Employees Does TransGenic Group Have?

TransGenic Group has 227 employees, based on their latest Companies House report.

What is the current trading status of TransGenic Group (Tokyo: 2342)?

As of 23/10/2026, TransGenic Group (2342) is trading at a share price of 207.0 JPY, with a previous close of 207.0 JPY. The stock has fluctuated within a day range of 204.0 JPY to 209.0 JPY, while its 52-week range spans from 182.0 JPY to 487.0 JPY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.